Land: Vereinigte Staaten
Sprache: Englisch
Quelle: NLM (National Library of Medicine)
PYRIMETHAMINE (UNII: Z3614QOX8W) (PYRIMETHAMINE - UNII:Z3614QOX8W), LEUCOVORIN CALCIUM (UNII: RPR1R4C0P4) (LEUCOVORIN - UNII:Q573I9DVLP)
ImprimisRx PA, Inc. d/b/a ImprimisRx
ORAL
PRESCRIPTION DRUG
unapproved drug other
PYRIMETHAMINE LEUCOVORIN- PYRIMETHAMINE LEUCOVORIN CAPSULE IMPRIMISRX PA, INC. D/B/A IMPRIMISRX _Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been_ _approved by FDA. For further information about unapproved drugs, click here._ ---------- PYRIMETHAMINE LEUCOVORIN (50MG-20MG) PYRIMETHAMINE LEUCOVORIN (50MG-20MG) PYRIMETHAMINE LEUCOVORIN pyrimethamine leucovorin capsule PRODUCT INFORMATION PRODUCT T YPE HUMAN PRESCRIPTION DRUG ITE M CODE (SOURCE ) NDC:70 271-429 ROUTE OF ADMINISTRATION ORAL ACTIVE INGREDIENT/ACTIVE MOIETY INGREDIENT NAME BASIS OF STRENGTH STRE NG TH PYRIMETHAMINE (UNII: Z36 14QOX8 W) (PYRIMETHAMINE - UNII:Z36 14QOX8 W) PYRIMETHAMINE 50 mg LEUCO VO RIN CALCIUM (UNII: RPR1R4C0 P4) (LEUCOVORIN - UNII:Q573I9 DVLP) LEUCOVORIN 20 mg INACTIVE INGREDIENTS INGREDIENT NAME STRE NG TH ImprimisRx PA, Inc. d/b/a ImprimisRx CELLULO SE, MICRO CRYSTALLINE (UNII: OP1R32D6 1U) 70 mg PRODUCT CHARACTERISTICS COLOR gray, pink S CORE no sco re S HAP E c a psule S IZ E 15mm FLAVOR IMPRINT CODE CONTAINS PACKAG ING # ITEM CODE PACKAGE DESCRIPTION MARKETING START DATE MARKETING END DATE 1 NDC:70 271-429 -0 1 10 0 in 1 BOTTLE; Type 0 : No t a Co mbinatio n Pro duct MARKETING INFORMATION MARKE TING CATE GORY APPLICATION NUMBE R OR MONOGRAPH CITATION MARKE TING START DATE MARKE TING END DATE unappro ved drug o ther 11/27/20 15 LABELER - ImprimisRx PA, Inc. d/b/a ImprimisRx (080044737) Revised: 11/2015 Lesen Sie das vollständige Dokument